Concourse Financial Group Securities’s ProPhase Labs PRPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-29
Closed -$1.52K 2372
2024
Q1
$1.89K Hold
29
﹤0.01% 2051
2023
Q4
$1.32K Hold
29
﹤0.01% 2078
2023
Q3
$1.28K Hold
29
﹤0.01% 2070
2023
Q2
$2.12K Hold
29
﹤0.01% 2008
2023
Q1
$2.23K Sell
29
-49
-63% -$3.95K ﹤0.01% 2041
2022
Q4
$7.54K Sell
78
-280
-78% -$30.3K ﹤0.01% 1743
2022
Q3
$40K Sell
358
-319
-47% -$37.1K ﹤0.01% 1042
2022
Q2
$86K Buy
+677
New +$59.5K 0.01% 869

Other funds holding PRPH

Concourse Financial Group Securities's PRPH Position: Q2 2024 in Review

Concourse Financial Group Securities sold out of ProPhase Labs (PRPH) in Q2 2024, closing a stake of 29 shares — an estimated $1.52K sold.

Concourse Financial Group Securities first reported a position in PRPH in Q2 2022 and held it in 8 quarters. The position peaked at $86K in Q2 2022. 29 funds tracked by Wall St. Rank hold PRPH as of Q2 2024.

  • Concourse Financial Group Securities reported no remaining ProPhase Labs position as of Q2 2024 after selling out during the quarter.
  • Concourse Financial Group Securities sold 29 ProPhase Labs shares in Q2 2024, an estimated $1.52K.
  • Concourse Financial Group Securities first reported a position in ProPhase Labs in Q2 2022 and held it in 8 quarters.
  • Concourse Financial Group Securities's ProPhase Labs position peaked at $86K in Q2 2022.
  • 29 funds tracked by Wall St. Rank held ProPhase Labs as of Q2 2024.

Based on Concourse Financial Group Securities's 13F filing for Q2 2024, filed 23 Jul 2024.